|
|
Name: |
Frazier Life Sciences Management L.P. |
City: |
Menlo Park |
State: |
CA |
Zip: |
94025 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
25 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
HLVX |
Hillevax, Inc. |
2 |
- |
$13.64 |
$156,993,000 |
9,781,472 |
8.39% |
25,432,000 |
0 |
29.26 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
3 |
- |
$0.00 |
$135,511,000 |
12,131,705 |
7.25% |
23,293,000 |
0 |
14.875 |
N/A |
|
KRYS |
Krystal Biotech Inc |
4 |
- |
$154.82 |
$122,628,000 |
988,460 |
6.56% |
7,967,000 |
0 |
3.968 |
N/A |
|
BBIO |
Bridgebio Pharma, Inc. |
5 |
- |
$28.50 |
$110,047,000 |
2,725,949 |
5.88% |
38,164,000 |
0 |
1.711 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
6 |
- |
$40.20 |
$109,009,000 |
2,371,304 |
5.83% |
54,647,000 |
0 |
3.865 |
N/A |
|
PHAT |
Phathom Pharmaceuticals, Inc. |
7 |
- |
$0.00 |
$92,298,000 |
10,109,279 |
4.93% |
-12,535,000 |
0 |
29.626 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
8 |
- |
$0.00 |
$73,125,000 |
1,164,405 |
3.91% |
13,764,000 |
0 |
1.08 |
N/A |
|
VRNA |
Verona Pharma Plc |
9 |
- |
$0.00 |
$59,925,000 |
3,014,349 |
3.2% |
10,791,000 |
0 |
4.11 |
N/A |
|
TARS |
Tarsus Pharmaceuticals, Inc. |
15 |
- |
$0.00 |
$36,197,000 |
1,787,527 |
1.94% |
4,433,000 |
0 |
6.702 |
N/A |
|
RVMD |
Revolution Medicines, Inc. |
17 |
- |
$37.17 |
$28,607,000 |
997,455 |
1.53% |
997,000 |
0 |
0.871 |
N/A |
|
ANTX |
An2 Therapeutics Ord Shs |
18 |
- |
$2.35 |
$28,458,000 |
1,388,889 |
1.52% |
6,125,000 |
0 |
7.156 |
N/A |
|
AVTE |
Aerovate Therapeutics, Inc. |
20 |
- |
$0.00 |
$27,266,000 |
1,204,867 |
1.46% |
10,916,000 |
0 |
4.545 |
N/A |
|
AUTL |
Autolus Therapeutics Plc |
21 |
- |
$4.01 |
$24,130,000 |
3,746,857 |
1.29% |
15,400,000 |
0 |
2.165 |
N/A |
|
MRUS |
Merus Nv |
25 |
- |
$45.85 |
$20,528,000 |
746,479 |
1.1% |
2,926,000 |
0 |
1.749 |
N/A |
|
ORIC |
Oric Pharmaceuticals, Inc. |
26 |
- |
$0.00 |
$19,714,000 |
2,142,855 |
1.05% |
6,750,000 |
0 |
5.45 |
N/A |
|
ANAB |
Anaptysbio Inc |
27 |
- |
$23.99 |
$19,272,000 |
899,700 |
1.03% |
3,113,000 |
0 |
2.829 |
N/A |
|
SVRA |
Savara Inc |
28 |
- |
$4.59 |
$18,800,000 |
4,000,000 |
1.01% |
3,680,000 |
0 |
3.513 |
Biotechnology |
|
SLNO |
Soleno Therapeutics Inc |
29 |
- |
$0.16 |
$18,714,000 |
464,937 |
1% |
4,994,000 |
0 |
0.584 |
N/A |
|
CERE |
Cerevel Therapeutics Holdin... |
30 |
- |
$42.06 |
$16,663,000 |
393,000 |
0.89% |
8,084,000 |
0 |
0.251 |
N/A |
|
SLN |
Silence Therapeutics Adr Re... |
34 |
- |
$0.00 |
$15,306,000 |
881,173 |
0.82% |
6,644,000 |
0 |
2.956 |
N/A |
|
ARVN |
Arvinas Holding Company, Llc |
38 |
- |
$31.57 |
$11,744,000 |
285,331 |
0.63% |
6,140,000 |
0 |
0.536 |
N/A |
|
APGE |
Apogee Therapeutics, Inc. |
41 |
- |
$52.73 |
$11,176,000 |
400,000 |
0.6% |
2,656,000 |
0 |
1.076 |
N/A |
|
NTLA |
Intellia Therapeutics, Inc. |
44 |
- |
$25.42 |
$6,210,000 |
203,684 |
0.33% |
-230,000 |
0 |
0.227 |
N/A |
|
BLUE |
Bluebird Bio, Inc. |
46 |
- |
$1.02 |
$2,360,000 |
1,709,907 |
0.13% |
-2,838,000 |
0 |
1.671 |
Biotechnology |
|
ACRS |
Aclaris Therapeutics, Inc. |
48 |
- |
$1.18 |
$278,000 |
264,377 |
0.01% |
-1,533,000 |
0 |
0.357 |
N/A |
|